InVentiv Health acquired ParagonRx, a consulting company specializing in pharma risk management and optimizing medication use. The acquisition is aimed at bolstering inVentiv’s Risk Evaluation and Mitigation Strategy offering . In the past year, the network noted, more than a quarter of all new drug approvals in the US included an FDA-approved REMS program.
Company News: InVentiv Health
InVentiv Health acquired ParagonRx, a consulting company specializing in pharma risk management and optimizing medication use. The acquisition is aimed at bolstering inVentiv's Risk Evaluation and Mitigation Strategy offering . In the past year, the network noted, more than a quarter of all new drug approvals in the US included an FDA-approved REMS program.
